Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-005327-27Phase 3
Phase 3 trial of Camphor and camphor + hawthorn berry extract in hypotension, sponsored by Robugen. Primary endpoint: Change of low blood pressure.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-005327-27.